Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ticiana A Leal

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Thoracic Disease|March 30, 2018
Immunotherapy in previously treated non-small cell lung cancer (NSCLC)Ticiana A Leal, Suresh S Ramalingam
Cell Reports. Medicine|July 20, 2022
Neoadjuvant therapy gains FDA approval in non-small cell lung cancerTiciana A Leal, Suresh S Ramalingam
Translational Lung Cancer Research|November 2, 2019
What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?Eric G Nesbit, Ticiana A Leal, Tim J Kruser
Cancer|February 27, 2023
Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-small cell lung cancerLiza C Villaruz, George R Blumenschein, Gregory A Otterson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2019
Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicitiesCatherine E Renna, Elizabeth N Dow, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 29, 2018
Implementing value assessment in oncology practice: A single-center experienceKatherine Saunders, Mary S Mably, Sara S Shull, et al.
JCO Global Oncology|March 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and JapanTiciana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
JCO Global Oncology|September 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United StatesStephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
ACS Applied Materials & Interfaces|May 9, 2018
Exclusive Liquid Repellency: An Open Multi-Liquid-Phase Technology for Rare Cell Culture and Single-Cell ProcessingChao Li, Jiaquan Yu, Jennifer Schehr, et al.
Current Medical Research and Opinion|July 4, 2020
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysisTiciana A Leal, Angela C Argento, Krish Bhadra, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Disease|March 30, 2018
Immunotherapy in previously treated non-small cell lung cancer (NSCLC)Ticiana A Leal, Suresh S Ramalingam
Cell Reports. Medicine|July 20, 2022
Neoadjuvant therapy gains FDA approval in non-small cell lung cancerTiciana A Leal, Suresh S Ramalingam
Translational Lung Cancer Research|November 2, 2019
What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?Eric G Nesbit, Ticiana A Leal, Tim J Kruser
Cancer|February 27, 2023
Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death-ligand 1 inhibitors in non-small cell lung cancerLiza C Villaruz, George R Blumenschein, Gregory A Otterson, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2019
Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicitiesCatherine E Renna, Elizabeth N Dow, Jason J Bergsbaken, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 29, 2018
Implementing value assessment in oncology practice: A single-center experienceKatherine Saunders, Mary S Mably, Sara S Shull, et al.
JCO Global Oncology|March 14, 2024
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and JapanTiciana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
JCO Global Oncology|September 20, 2024
Real-World Outcomes of First-Line Treatment With Anti-PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United StatesStephen V Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau, et al.
ACS Applied Materials & Interfaces|May 9, 2018
Exclusive Liquid Repellency: An Open Multi-Liquid-Phase Technology for Rare Cell Culture and Single-Cell ProcessingChao Li, Jiaquan Yu, Jennifer Schehr, et al.
Current Medical Research and Opinion|July 4, 2020
Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysisTiciana A Leal, Angela C Argento, Krish Bhadra, et al.
Pageof 4